Unraveling Endocrine FGF Signaling Complex to Combat Metabolic Diseases.

Luo, Yongde; Lu, Weiqin; Li, Xiaokun

Luo, Yongde; Lu, Weiqin; Li, Xiaokun.

Afiliação

Luo Y; School of Pharmaceutical Science, Wenzhou Medical University and Center for Cancer and Metabolism Research, Institute for Life Science, Wenzhou University, Wenzhou, Zhejiang 325000, China; Proteomics and Nanotechnology Laboratory, Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX, USA; Current address: Centeer BioTherapeutics Ltd Co., Houston, TX 77021, USA. Electronic address: yluo99@centeerbiotherapeuti
Lu W; Division of Gastroenterology and Hepatology, Department of Medicine, Stony Brook University School of Medicine, 101 Nicolls Rd, Stony Brook, NY 11794, USA. Electronic address: Weiqin.Lu@stonybrookmedicine.edu.
Li X; School of Pharmaceutical Science, Wenzhou Medical University and Center for Cancer and Metabolism Research, Institute for Life Science, Wenzhou University, Wenzhou, Zhejiang 325000, China. Electronic address: lixk1964@163.com.

Trends Biochem Sci ; 43(8): 563-566, 2018 08.

Article em En | MEDLINE | ID: mdl-29895507

Assuntos

Doenças Metabólicas; Transdução de Sinais; Comunicação Celular; Fator de Crescimento de Fibroblastos 23; Homeostase; Humanos

Palavras-chave

FGF21; FGF23; FGFR; Klotho; heparan sulfate; metabolic diseases

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Doenças Metabólicas Limite: Humans Idioma: En Revista: Trends Biochem Sci Ano de publicação: 2018 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google